» Articles » PMID: 2037657

Occurrence of Staphylococcus Lugdunensis in Consecutive Clinical Cultures and Relationship of Isolation to Infection

Overview
Specialty Microbiology
Date 1991 Mar 1
PMID 2037657
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Consecutive record review over a 63-month period revealed 229 Staphylococcus lugdunensis isolates, or 10.1% of the staphylococcal species that were not Staphylococcus aureus or Staphylococcus epidermidis. A total of 155 S. lugdunensis specimens were isolated from sites over the entire bodies of the 143 patients studied. The most common clinical diagnoses were skin and skin structure infections (55.4%) and blood and vascular catheter infections (17.4%). For 40% of the reviewed specimens, S. lugdunensis was the sole agent isolated, and for 60% of specimens, S. lugdunensis was isolated as part of mixed flora. In only 15.4% of clinically reviewed specimens was S. lugdunensis clearly a culture contaminant or colonizing organism. The pattern of human infection identified in this study emphasizes the predominance of skin and soft tissue S. lugdunensis infections over deep serious infections such as endocarditis, peritonitis, infected hip prosthesis, and osteomyelitis and vascular-associated infections. S. lugdunensis should be included along with S. epidermidis, Staphylococcus haemolyticus, and Staphylococcus saprophyticus as a coagulase-negative species of Staphylococcus pathogenic for humans.

Citing Articles

Automatic Implantable Cardioverter Defibrillator Lead-related Endocarditis due to Staphylococcus lugdunensis.

Thota G, Joseph B, Shah M, Redel H, Yeruva K, Patel K Brown J Hosp Med. 2025; 2(2):73883.

PMID: 40046152 PMC: 11878827. DOI: 10.56305/001c.73883.


Clinical Disease and Outcomes of Invasive Staphylococcus lugdunensis Infection in a University Hospital in Saudi Arabia.

Kaki R Cureus. 2024; 16(1):e52103.

PMID: 38344484 PMC: 10858730. DOI: 10.7759/cureus.52103.


A Rare Case of Staphylococcus lugdunensis Causing a Pseudoaneurysm of the Aorta.

Huynh P, Mathew A, Buradkar A, Kharbanda P, Rauniyar R Cureus. 2022; 14(4):e24530.

PMID: 35651444 PMC: 9138200. DOI: 10.7759/cureus.24530.


Staphylococcus lugdunensis Urinary Tract Infection With Associated Neutropenic Fever.

Bobde R, Berger J, Jalil U, Kalaydjian G Cureus. 2022; 14(1):e21432.

PMID: 35223221 PMC: 8860714. DOI: 10.7759/cureus.21432.


Antimicrobial Susceptibility Testing for Staphylococcus lugdunensis.

Teh J, Pantelis I, Chen X, Sadlon T, Papanaoum K, Gordon D J Clin Microbiol. 2021; 60(1):e0320220.

PMID: 34705537 PMC: 8769745. DOI: 10.1128/JCM.03202-20.


References
1.
Pfaller M, Herwaldt L . Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev. 1988; 1(3):281-99. PMC: 358051. DOI: 10.1128/CMR.1.3.281. View

2.
Etienne J, Pangon B, Leport C, Wolff M, Clair B, Perronne C . Staphylococcus lugdunensis endocarditis. Lancet. 1989; 1(8634):390. DOI: 10.1016/s0140-6736(89)91770-4. View

3.
HEBERT G . Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi. J Clin Microbiol. 1990; 28(11):2425-31. PMC: 268200. DOI: 10.1128/jcm.28.11.2425-2431.1990. View

4.
Walsh B, MOUNSEY J . Staphylococcus lugdenensis and endocarditis. J Clin Pathol. 1990; 43(2):171. PMC: 502305. DOI: 10.1136/jcp.43.2.171-a. View

5.
Fleurette J, Bes M, Brun Y, Freney J, Forey F, COULET M . Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol. 1989; 140(2):107-18. DOI: 10.1016/0923-2508(89)90044-2. View